Cargando…

Data sharing and privacy issues arising with COVID-19 data and applications

The coronavirus disease 2019 (COVID-19) (2019-nCov), which was first detected in Wuhan/China in December 2019 and spread to the whole world in a short time, was explained as a new coronavirus by the World Health Organization on February 11, 2020. Countries are developing various strategies against t...

Descripción completa

Detalles Bibliográficos
Autores principales: Müftüoğlu, Z., Kızrak, M.A., Yıldırım, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988992/
http://dx.doi.org/10.1016/B978-0-323-90769-9.00003-7
_version_ 1784683076283006976
author Müftüoğlu, Z.
Kızrak, M.A.
Yıldırım, T.
author_facet Müftüoğlu, Z.
Kızrak, M.A.
Yıldırım, T.
author_sort Müftüoğlu, Z.
collection PubMed
description The coronavirus disease 2019 (COVID-19) (2019-nCov), which was first detected in Wuhan/China in December 2019 and spread to the whole world in a short time, was explained as a new coronavirus by the World Health Organization on February 11, 2020. Countries are developing various strategies against the spread of epidemic threat. The main ones are to develop web-based or mobile applications to reduce the spread and economic damage of the epidemic by making use of COVID-19 datasets. It is seen that the existing applications developed within the framework of these expectations contain absolute location information (direct), relative location information (indirect), and characteristic data defining people. Even if these data mean a lot to the world's struggle with COVID-19, it is necessary to foresee the risks that may occur after the epidemic when the relations of the information are considered. In order to measure the privacy risk of this kind of applications containing personal data, privacy metrics have been defined in the literature. In this chapter, we give a perspective about the sharing and privacy of medical data within the scope of COVID-19. Within this context, privacy models, metrics, and approaches for selecting the appropriate model are described, in particular for COVID-19 applications, and we also propose a new metric with the entropy approach to metrics defined in the literature and effective in determining the privacy score.
format Online
Article
Text
id pubmed-8988992
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-89889922022-04-11 Data sharing and privacy issues arising with COVID-19 data and applications Müftüoğlu, Z. Kızrak, M.A. Yıldırım, T. Data Science for COVID-19 Article The coronavirus disease 2019 (COVID-19) (2019-nCov), which was first detected in Wuhan/China in December 2019 and spread to the whole world in a short time, was explained as a new coronavirus by the World Health Organization on February 11, 2020. Countries are developing various strategies against the spread of epidemic threat. The main ones are to develop web-based or mobile applications to reduce the spread and economic damage of the epidemic by making use of COVID-19 datasets. It is seen that the existing applications developed within the framework of these expectations contain absolute location information (direct), relative location information (indirect), and characteristic data defining people. Even if these data mean a lot to the world's struggle with COVID-19, it is necessary to foresee the risks that may occur after the epidemic when the relations of the information are considered. In order to measure the privacy risk of this kind of applications containing personal data, privacy metrics have been defined in the literature. In this chapter, we give a perspective about the sharing and privacy of medical data within the scope of COVID-19. Within this context, privacy models, metrics, and approaches for selecting the appropriate model are described, in particular for COVID-19 applications, and we also propose a new metric with the entropy approach to metrics defined in the literature and effective in determining the privacy score. 2022 2022-01-14 /pmc/articles/PMC8988992/ http://dx.doi.org/10.1016/B978-0-323-90769-9.00003-7 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Müftüoğlu, Z.
Kızrak, M.A.
Yıldırım, T.
Data sharing and privacy issues arising with COVID-19 data and applications
title Data sharing and privacy issues arising with COVID-19 data and applications
title_full Data sharing and privacy issues arising with COVID-19 data and applications
title_fullStr Data sharing and privacy issues arising with COVID-19 data and applications
title_full_unstemmed Data sharing and privacy issues arising with COVID-19 data and applications
title_short Data sharing and privacy issues arising with COVID-19 data and applications
title_sort data sharing and privacy issues arising with covid-19 data and applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988992/
http://dx.doi.org/10.1016/B978-0-323-90769-9.00003-7
work_keys_str_mv AT muftuogluz datasharingandprivacyissuesarisingwithcovid19dataandapplications
AT kızrakma datasharingandprivacyissuesarisingwithcovid19dataandapplications
AT yıldırımt datasharingandprivacyissuesarisingwithcovid19dataandapplications